Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cadrenal Therapeutics, Inc. | Chief Financial Officer | Common Stock | 500K | $345K | $0.69 | Jan 24, 2023 | Direct |
S&W Seed Co | EVP Finance & Admin and CFO | Common Stock | 138K | $73.1K | $0.53 | Oct 5, 2021 | Direct |
SenesTech, Inc. | Director | Stock Option (right to buy) | 12.1K | $37.3K | $0.95 | Aug 27, 2024 | Direct |
Cadrenal Therapeutics, Inc. | Chief Financial Officer | Stock Options | 250K | Jan 18, 2024 | Direct | ||
INVO Bioscience, Inc. | Director | Stock Option (right to buy) | 85K | May 18, 2023 | Direct | ||
S&W Seed Co | EVP Finance & Admin and CFO | Stock option (right to buy) | 80K | Oct 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SNES | SenesTech, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Aug 28, 2024 | Director |
CVKD | Cadrenal Therapeutics, Inc. | Jan 18, 2024 | 1 | $0 | 4 | Jan 19, 2024 | Chief Financial Officer |
SNES | SenesTech, Inc. | Jun 26, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
INVO | INVO Bioscience, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
CVKD | Cadrenal Therapeutics, Inc. | Jan 24, 2023 | 1 | $0 | 4 | Jan 24, 2023 | Chief Financial Officer |
CVKD | Cadrenal Therapeutics, Inc. | Jan 19, 2023 | 0 | $0 | 3 | Jan 19, 2023 | Chief Financial Officer |
SNES | SenesTech, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
INVO | INVO Bioscience, Inc. | Jun 1, 2022 | 1 | $13.8K | 4 | Jun 3, 2022 | Director |
INVO | INVO Bioscience, Inc. | Jan 15, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
SANW | S&W Seed Co | Oct 5, 2021 | 2 | $0 | 4 | Oct 7, 2021 | EVP Finance & Admin and CFO |
SANW | S&W Seed Co | Oct 1, 2021 | 1 | -$3.83K | 4 | Oct 4, 2021 | EVP Finance & Admin and CFO |
SANW | S&W Seed Co | Jul 1, 2021 | 3 | -$6.68K | 4 | Jul 6, 2021 | EVP Finance & Admin and CFO |
SNES | SenesTech, Inc. | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |